Rombotis Spiro George 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 26, 2023
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Purchase
Warrants (right to buy)
2023-12-21+6,070→ 6,070 totalExercise: $3.19From: 2023-12-21Exp: 2030-12-21→ Common Stock (6,070 underlying) - Purchase
Common Stock
2023-12-21$3.31/sh+6,070$20,122→ 68,658 total
Footnotes (2)
- [F1]The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer.
- [F2]Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant.